secwatch / observer
8-K filed August 30, 2021, 7:59 PM ET ticker HUMA CIK 0001818382
M&A confidence high sentiment positive materiality 0.95

Humacyte completes SPAC merger; begins trading as HUMA; $175M PIPE investment closed

Humacyte, Inc.

item 1.01item 2.01item 5.06item 9.01item 5.02item 3.02item 4.01item 3.03item 5.01item 5.03item 7.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Heather Prichard

Chief Operating Officer
HUMA · Humacyte, Inc.
Effective
2021-08-26
Filed
August 30, 2021, 7:59 PM ET
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
Appointed

Laura E. Niklason

President, Chief Executive Officer and Director
HUMA · Humacyte, Inc.
Effective
2021-08-26
Filed
August 30, 2021, 7:59 PM ET
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
Appointed

Dale A. Sander

Chief Financial Officer, Chief Corporate Development Officer and Treasurer
HUMA · Humacyte, Inc.
Effective
2021-08-26
Filed
August 30, 2021, 7:59 PM ET
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
Appointed

William (B.J.) Scheessele

Chief Commercial Officer
HUMA · Humacyte, Inc.
Effective
2021-08-26
Filed
August 30, 2021, 7:59 PM ET
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
Appointed

Jeffrey H. Lawson

Chief Surgical Officer and Director
HUMA · Humacyte, Inc.
Effective
2021-08-26
Filed
August 30, 2021, 7:59 PM ET
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
Appointed

William Tente

Chief Regulatory Officer
HUMA · Humacyte, Inc.
Effective
2021-08-26
Filed
August 30, 2021, 7:59 PM ET
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
Appointed

Kiernan T. DeAngelis

Chief Medical Officer
HUMA · Humacyte, Inc.
Effective
2021-08-26
Filed
August 30, 2021, 7:59 PM ET
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Heather Prichard was appointed as Chief Operating Officer at Humacyte, Inc..

Action
appointed
Role
Chief Operating Officer
Exact text from the filing
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Laura E. Niklason was appointed as President, Chief Executive Officer and Director at Humacyte, Inc..

Action
appointed
Role
President, Chief Executive Officer and Director
Exact text from the filing
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dale A. Sander was appointed as Chief Financial Officer, Chief Corporate Development Officer and Treasurer at Humacyte, Inc..

Action
appointed
Role
Chief Financial Officer, Chief Corporate Development Officer and Treasurer
Exact text from the filing
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William (B.J.) Scheessele was appointed as Chief Commercial Officer at Humacyte, Inc..

Action
appointed
Role
Chief Commercial Officer
Exact text from the filing
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey H. Lawson was appointed as Chief Surgical Officer and Director at Humacyte, Inc..

Action
appointed
Role
Chief Surgical Officer and Director
Exact text from the filing
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William Tente was appointed as Chief Regulatory Officer at Humacyte, Inc..

Action
appointed
Role
Chief Regulatory Officer
Exact text from the filing
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kiernan T. DeAngelis was appointed as Chief Medical Officer at Humacyte, Inc..

Action
appointed
Role
Chief Medical Officer
Exact text from the filing
Executive Officers Upon consummation of the Business Combination, the following individuals were appointed to serve as executive officers of Humacyte: Name Age Position(s) Laura E. Niklason 58 President, Chief Executive Officer and Director Dale A. Sander 61 Chief Financial Officer, Chief Corporate Development Officer and Treasurer Heather Prichard 44 Chief Operating Officer William Tente 64 Chief Regulatory Officer Jeffrey H. Lawson 57 Chief Surgical Officer and Director Kiernan T. DeAngelis 51 Chief Medical Officer William (B.J.) Scheessele 50 Chief Commercial Officer
View on SEC.gov

Humacyte, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-21-110678
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.